In recent years, a steady improvement in survival after radical surgery for esophageal carcinoma has been observed. Earlier detection, refinements in surgical technique, perioperative management, and adjunctive chemo/radiotherapy regimens1,2 have led to a substantial increase in both overall- and disease-free survival, with 40% of patients alive up to 5 years after radical surgery.3
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.